BLT 0.00% 2.6¢ benitec biopharma limited

casey analyst forecasts explosive biotech grow

  1. 520 Posts.
    Casey Analyst Forecasts Explosive Biotech Growth

    http://jutiagroup.com/20121011-casey-analy...biotech-growth/

    from the URL above
    It’ll start with a trickle, more than a flood. But make no mistake: RNAi, or temporary gene silencing through interference with the messenger RNA that signal
    cell behavior, looks to be one of the most important genetic treatment
    methodologies yet conceived.
    Genetics are at the root of just about every major chronic disease—heart disease, cancer, diabetes. Gene silencing has serious promise with regard to controlling the root causes and predispositions for some of these maladies, instead of waging continuous battles against symptoms, as we do today.


 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.